Liabilities / Assets
22nd percentile
Higher debt load relative to assets than 22% of similar nonprofits.
990 • Fiscal year 2015 • EIN 59-3432665
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
22nd percentile
Higher debt load relative to assets than 22% of similar nonprofits.
Liabilities / Revenue
48th percentile
Higher debt load relative to revenue than 48% of similar nonprofits.
Net Margin
89th percentile
Higher net margin than 89% of similar nonprofits.
Top Officer Pay
34th percentile
Higher top officer pay than 34% of similar nonprofits.
Top officer pay equals 9.2% of source-year revenue.
Asset Growth
64th percentile
Faster asset growth than 64% of similar nonprofits.
Revenue Growth
49th percentile
Faster revenue growth than 49% of similar nonprofits.
Assets
Up$7,717,237
Up $336,652 (+4.6%) from 2014
Net Assets
Up$7,555,290
Up $453,851 (+6.4%) from 2014
Liabilities
Down$161,947
Down $117,199 (-42%) from 2014
Revenue
Up$959,466
Up $30,087 (+3.2%) from 2014
Expenses
Down$568,606
Down $14,674 (-2.5%) from 2014
Net Income
Up$390,860
Up $44,761 (+13%) from 2014
Frontiers in bioscience ia an organizatioj dedicated to fostering science, research and teaching. Fbs has been invo;ve in these activities since jan. 1 1996. Fbs has published ober 4000 scholarly scientific articles in medicine and biology from well known scientists. Fbs also carries research in understanding cancer since 2007 and has been working on aging reversal since 2011. Our research on cancer is geared towards understanding the reason for cancer growth and reurranxce as well as understanding the cause of disturbed metabolism of cancer cells in order to gain an insight to provide new avenues for treatment. We use stem cells as well as signaling molecules to acheive the therapeutic end.
Frontiers in bioscience is an organization dedicated to fostering science, research and teaching. Fbs has been involved in these activities since jan 1 1996. Fbs has published over 4000 scholarly scientific articles in medicine and biology from well known scientists. Fbs also carries research in understanding cancer since 2007 and has been working on aging reversal since 2011. Our research on cancer is geared towards understanding the reason for cancer growth and recurrence as well as understanding the cause of disturbed metabolism (warburg's effect) of cancer cells. Such an insight is significant since it provides us with new avenues for treatment of cancer or cancer cure. The treatment of cancer based, on our hypothesis, is founded on new non-chemotherapeutic and non-radiotherpay approaches. We also examine the cause of senescence, as well as approaches for reversal or deceleration of this process. Based on such a background, we will examine whether senescence can be reversed or dece
| Line | Beginning | End | Change |
|---|---|---|---|
| Assets | |||
| Land, Buildings, and Equipment, Net | $2,953,105 | $4,678,218 | ▲ $1,725,113 |
| Cash and Non-Interest-Bearing Accounts | $4,414,641 | $3,034,342 | ▼ $1,380,299 |
| Loans From Officers Directors | $251,396 | $159,953 | ▼ $91,443 |
| Investments in Publicly Traded Securities | $4,660 | $4,660 | → $0 |
| Other Notes and Loans Receivable, Net | $8,179 | $17 | ▼ $8,162 |
| Total Assets | $7,380,585 | $7,717,237 | ▲ $336,652 |
| Liabilities | |||
| Accounts Payable and Accrued Expenses | $27,750 | $1,994 | ▼ $25,756 |
| Total Liabilities | $279,146 | $161,947 | ▼ $117,199 |
| Net Assets / Fund Balance | |||
| Unrestricted Net Assets | $7,101,439 | $7,555,290 | ▲ $453,851 |
| Total Net Assets Fund Balance | $7,101,439 | $7,555,290 | ▲ $453,851 |
| Total Liabilities and Net Assets / Fund Balance | $7,380,585 | $7,717,237 | ▲ $336,652 |
| Asset | Book Value | Depreciation | Basis |
|---|---|---|---|
| Land | $2,854,413 | - | $1,555,474 |
| Buildings | $1,727,243 | $251,702 | $1,227,758 |
| Equipment | $72,799 | $271,419 | $344,218 |
| Other Land Buildings | $23,763 | $46,292 | $70,055 |
| Name | Title | Full / Part Time | Base | Total |
|---|---|---|---|---|
| Siamak Tabibzadeh Md | President/ce | FT | $88,000 | $88,000 |
| Elena Ostrakhovitch | Secretary | FT | $48,502 | $48,502 |
| Name | Title |
|---|---|
| Shila Roofim | Director / T |
| Line Item | Amount |
|---|---|
| Other Expenses | $291,069 |
| Salaries, Compensation, and Employee Benefits | $277,537 |
| Total Fundraising Expense | $11,705 |
| Grants and Similar Amounts Paid | $0 |
| Professional Fundraising Fees | $0 |
| Line Item | Program | Management | Fundraising | Total |
|---|---|---|---|---|
| Other Salaries and Wages | $160,481 | - | - | $160,481 |
| Current Officers, Directors, Trustees, and Key Employees | $70,400 | $8,800 | $8,800 | $88,000 |
| All Other Expenses | $74,458 | - | - | $74,458 |
| Depreciation Depletion | $69,135 | - | - | $69,135 |
| Payroll Taxes | $16,082 | $2,010 | $2,010 | $20,102 |
| Other Expenses | $14,378 | - | - | $14,378 |
| Occupancy | $13,478 | - | - | $13,478 |
| Other Employee Benefits | $7,164 | $895 | $895 | $8,954 |
| Fees for Services Other | $7,888 | - | - | $7,888 |
| Insurance | $7,117 | - | - | $7,117 |
| Fees for Services Accounting | - | $6,916 | - | $6,916 |
| Office Expenses | $4,765 | - | - | $4,765 |
| Travel | $3,369 | - | - | $3,369 |
| Information Technology | $1,764 | - | - | $1,764 |
| Fees for Services Legal | - | $500 | - | $500 |
| Interest | - | $166 | - | $166 |
| Total Functional Expenses | $537,614 | $19,287 | $11,705 | $568,606 |
| Line Item | Amount |
|---|---|
| Professional Fundraising Fees | $0 |
| Interested Party | Relationship | Description | Shared Revenue | Amount |
|---|---|---|---|---|
| Siamak Tabibzadeh | CEO | Lead Investigator | No | $88,000 |
| Line Item | Beginning | End | Change |
|---|---|---|---|
| Loans from Officers, Directors, Trustees, and Key Employees | $251,396 | $159,953 | ▼ $91,443 |
“The form 990 is reviewed with the cpa consultant as to accuracy and completeness.”
“Conflict of interest policy - the board of directors reviews self-dealing transactions regularly.”
“AVAIABLE UPON REQUEST.”
“Frontiers in bioscience is an organization dedicated to fostering science, research and teaching. Fbs has been involved in these activities since jan 1 1996. Fbs has published over 4000 scholarly scientific articles in medicine and biology from well known scientists. Fbs also carries research in understanding cancer since 2007 and has been working on aging reversal since 2011. Our research on cancer is geared towards understanding the reason for cancer growth and recurrence as well as understanding the cause of disturbed metabolism (warburg's effect) of cancer cells. Such an insight is significant since it provides us with new avenues for treatment of cancer or cancer cure. The treatment of cancer based, on our hypothesis, is founded on new non-chemotherapeutic and non-radiotherpay approaches. We also examine the cause of senescence, as well as approaches for reversal or deceleration of this process. Based on such a background, we will examine whether senescence can be reversed or decelarated in animal modes before they can be adopted in humans. We will use stem cells as well signaling molecules to achieve such therapeutic end. We hope that our findings will help humanity in a grand scale.”
“Also examine the cause of senescence, as well as approaches for reversal or deceleration of this process. Based on such a background, we will examine whether senescence can be reversed or decelarated in animal modes before they can be adopted in humans. We will use stem cells as well signaling molecules to achieve such therapeutic end. We hope that our findings will help humanity in a grand scale.”
“Association dues 14,126 0 0 merchant service fees 13,160 0 0 transportation 12,358 0 0 souith crescent - building 7,939 0 0 1080 park - building 7,548 0 0 communications 6,980 0 0 pacific promenade - building 5,005 0 0 investment management fee 4,021 0 0 investment other 1,517 0 0 events 1,399 0 0 books and publications 405 0 0”
“Officer loan interest accrued-current 0 officer loan interest accrued-prior 0 officer loan interest accrual 0”
This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.
| Path | # | Value |
|---|---|---|
| IRS990/AccountantCompileOrReviewInd | 0 | false |
| IRS990/AccountsPayableAccrExpnssGrp/BOYAmt | 0 | 27750 |
| IRS990/AccountsPayableAccrExpnssGrp/EOYAmt | 0 | 1994 |
| IRS990/ActivitiesConductedPrtshpInd | 0 | false |
| IRS990/ActivityOrMissionDesc | 0 | FRONTIERS IN BIOSCIENCE IS AN ORGANIZATION DEDICATED TO FOSTERING SCIENCE, RESEARCH AND TEACHING. FBS HAS BEEN INVOLVED IN THESE ACTIVITIES SINCE JAN 1 1996. FBS HAS PUBLISHED OVER 4000 SCHOLARLY SCIENTIFIC ARTICLES IN MEDICINE AND BIOLOGY FROM WELL KNOWN SCIENTISTS. FBS ALSO CARRIES RESEARCH IN UNDERSTANDING CANCER SINCE 2007 AND HAS BEEN WORKING ON AGING REVERSAL SINCE 2011. OUR RESEARCH ON CANCER IS GEARED TOWARDS UNDERSTANDING THE REASON FOR CANCER GROWTH AND RECURRENCE AS WELL AS UNDERSTANDING THE CAUSE OF DISTURBED METABOLISM (WARBURG'S EFFECT) OF CANCER CELLS. SUCH AN INSIGHT IS SIGNIFICANT SINCE IT PROVIDES US WITH NEW AVENUES FOR TREATMENT OF CANCER OR CANCER CURE. THE TREATMENT OF CANCER BASED, ON OUR HYPOTHESIS, IS FOUNDED ON NEW NON-CHEMOTHERAPEUTIC AND NON-RADIOTHERPAY APPROACHES. WE ALSO EXAMINE THE CAUSE OF SENESCENCE, AS WELL AS APPROACHES FOR REVERSAL OR DECELERATION OF THIS PROCESS. BASED ON SUCH A BACKGROUND, WE WILL EXAMINE WHETHER SENESCENCE CAN BE REVERSED OR DECE |
| IRS990/AllOtherExpensesGrp/ProgramServicesAmt | 0 | 74458 |
| IRS990/AllOtherExpensesGrp/TotalAmt | 0 | 74458 |
| IRS990/AnnualDisclosureCoveredPrsnInd | 0 | true |
| IRS990/BooksInCareOfDetail/PersonNm | 0 | SIAMAK TABIBZADEH MD |
| IRS990/BooksInCareOfDetail/PhoneNum | 0 | 9497158286 |
| IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt | 0 | 20 SUNSET COVE |
| IRS990/BooksInCareOfDetail/USAddress/CityNm | 0 | NEWPORT COAST |
| IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd | 0 | CA |
| IRS990/BooksInCareOfDetail/USAddress/ZIPCd | 0 | 92657 |
| IRS990/BusinessRlnWithFamMemInd | 0 | true |
| IRS990/BusinessRlnWithOfficerEntInd | 0 | false |
| IRS990/BusinessRlnWithOrgMemInd | 0 | true |
| IRS990/CashNonInterestBearingGrp/BOYAmt | 0 | 4414641 |
| IRS990/CashNonInterestBearingGrp/EOYAmt | 0 | 3034342 |
| IRS990/ChangeToOrgDocumentsInd | 0 | false |
| IRS990/CollectionsOfArtInd | 0 | false |
| IRS990/CompCurrentOfcrDirectorsGrp/FundraisingAmt | 0 | 8800 |
| IRS990/CompCurrentOfcrDirectorsGrp/ManagementAndGeneralAmt | 0 | 8800 |
| IRS990/CompCurrentOfcrDirectorsGrp/ProgramServicesAmt | 0 | 70400 |
| IRS990/CompCurrentOfcrDirectorsGrp/TotalAmt | 0 | 88000 |
| IRS990/CompensationFromOtherSrcsInd | 0 | false |
| IRS990/CompensationProcessCEOInd | 0 | false |
| IRS990/CompensationProcessOtherInd | 0 | false |
| IRS990/ConflictOfInterestPolicyInd | 0 | true |
| IRS990/ConservationEasementsInd | 0 | false |
| IRS990/ConsolidatedAuditFinclStmtInd | 0 | false |
| IRS990/CreditCounselingInd | 0 | false |
| IRS990/CYBenefitsPaidToMembersAmt | 0 | 0 |
| IRS990/CYContributionsGrantsAmt | 0 | 0 |
| IRS990/CYGrantsAndSimilarPaidAmt | 0 | 0 |
| IRS990/CYInvestmentIncomeAmt | 0 | 57283 |
| IRS990/CYOtherExpensesAmt | 0 | 291069 |
| IRS990/CYOtherRevenueAmt | 0 | 0 |
| IRS990/CYProgramServiceRevenueAmt | 0 | 902183 |
| IRS990/CYRevenuesLessExpensesAmt | 0 | 390860 |
| IRS990/CYSalariesCompEmpBnftPaidAmt | 0 | 277537 |
| IRS990/CYTotalExpensesAmt | 0 | 568606 |
| IRS990/CYTotalFundraisingExpenseAmt | 0 | 11705 |
| IRS990/CYTotalProfFndrsngExpnsAmt | 0 | 0 |
| IRS990/CYTotalRevenueAmt | 0 | 959466 |
| IRS990/DecisionsSubjectToApprovaInd | 0 | false |
| IRS990/DeductibleArtContributionInd | 0 | false |
| IRS990/DeductibleNonCashContriInd | 0 | false |
| IRS990/DelegationOfMgmtDutiesInd | 0 | false |
| IRS990/DepreciationDepletionGrp/ProgramServicesAmt | 0 | 69135 |
| IRS990/DepreciationDepletionGrp/TotalAmt | 0 | 69135 |
| IRS990/Desc | 0 | FRONTIERS IN BIOSCIENCE IS AN ORGANIZATION DEDICATED TO FOSTERING SCIENCE, RESEARCH AND TEACHING. FBS HAS BEEN INVOLVED IN THESE ACTIVITIES SINCE JAN 1 1996. FBS HAS PUBLISHED OVER 4000 SCHOLARLY SCIENTIFIC ARTICLES IN MEDICINE AND BIOLOGY FROM WELL KNOWN SCIENTISTS. FBS ALSO CARRIES RESEARCH IN UNDERSTANDING CANCER SINCE 2007 AND HAS BEEN WORKING ON AGING REVERSAL SINCE 2011. OUR RESEARCH ON CANCER IS GEARED TOWARDS UNDERSTANDING THE REASON FOR CANCER GROWTH AND RECURRENCE AS WELL AS UNDERSTANDING THE CAUSE OF DISTURBED METABOLISM (WARBURG'S EFFECT) OF CANCER CELLS. SUCH AN INSIGHT IS SIGNIFICANT SINCE IT PROVIDES US WITH NEW AVENUES FOR TREATMENT OF CANCER OR CANCER CURE. THE TREATMENT OF CANCER BASED, ON OUR HYPOTHESIS, IS FOUNDED ON NEW NON-CHEMOTHERAPEUTIC AND NON-RADIOTHERPAY APPROACHES. WE ALSO EXAMINE THE CAUSE OF SENESCENCE, AS WELL AS APPROACHES FOR REVERSAL OR DECELERATION OF THIS PROCESS. BASED ON SUCH A BACKGROUND, WE WILL EXAMINE WHETHER SENESCENCE CAN BE REVERSED OR DECELARATED IN ANIMAL MODES BEFORE THEY CAN BE ADOPTED IN HUMANS. WE WILL USE STEM CELLS AS WELL SIGNALING MOLECULES TO ACHIEVE SUCH THERAPEUTIC END. WE HOPE THAT OUR FINDINGS WILL HELP HUMANITY IN A GRAND SCALE. |
| IRS990/DescribedInSection501c3Ind | 0 | true |
| IRS990/DisregardedEntityInd | 0 | false |
| IRS990/DocumentRetentionPolicyInd | 0 | true |
| IRS990/DonorAdvisedFundInd | 0 | false |
| IRS990/ElectionOfBoardMembersInd | 0 | false |
| IRS990/EmployeeCnt | 0 | 6 |
| IRS990/EmploymentTaxReturnsFiledInd | 0 | false |
| IRS990/EngagedInExcessBenefitTransInd | 0 | false |
| IRS990/ExpenseAmt | 0 | 537614 |
| IRS990/FamilyOrBusinessRlnInd | 0 | false |
| IRS990/FederalGrantAuditRequiredInd | 0 | false |
| IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt | 0 | 6916 |
| IRS990/FeesForServicesAccountingGrp/TotalAmt | 0 | 6916 |
| IRS990/FeesForServicesLegalGrp/ManagementAndGeneralAmt | 0 | 500 |
| IRS990/FeesForServicesLegalGrp/TotalAmt | 0 | 500 |
| IRS990/FeesForServicesOtherGrp/ProgramServicesAmt | 0 | 7888 |
| IRS990/FeesForServicesOtherGrp/TotalAmt | 0 | 7888 |
| IRS990/ForeignActivitiesInd | 0 | false |
| IRS990/ForeignFinancialAccountInd | 0 | false |
| IRS990/ForeignOfficeInd | 0 | false |
| IRS990/Form8282PropertyDisposedOfInd | 0 | false |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 0 | 40.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 1 | 40.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 2 | 2.00 |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 0 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 1 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 2 | X |
| IRS990/Form990PartVIISectionAGrp/OfficerInd | 0 | X |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 0 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 1 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 2 | 0 |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 0 | SIAMAK TABIBZADEH MD |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 1 | ELENA OSTRAKHOVITCH |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 2 | SHILA ROOFIM |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 0 | 88000 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 1 | 48502 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 2 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 0 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 1 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 2 | 0 |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 0 | PRESIDENT/CE |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 1 | SECRETARY |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 2 | DIRECTOR / T |
| IRS990/Form990ProvidedToGvrnBodyInd | 0 | true |
| IRS990/Form990TFiledInd | 0 | true |
| IRS990/FormationYr | 0 | 1995 |
| IRS990/FormerOfcrEmployeesListedInd | 0 | false |
| IRS990/FSAuditedInd | 0 | false |
| IRS990/FundraisingActivitiesInd | 0 | false |
| IRS990/GamingActivitiesInd | 0 | false |
| IRS990/GoverningBodyVotingMembersCnt | 0 | 5 |
| IRS990/GrantsToIndividualsInd | 0 | false |
| IRS990/GrantsToOrganizationsInd | 0 | false |
| IRS990/GrantToRelatedPersonInd | 0 | false |
| IRS990/GrossReceiptsAmt | 0 | 959466 |
| IRS990/GroupReturnForAffiliatesInd | 0 | false |
| IRS990/IncludeFIN48FootnoteInd | 0 | false |
| IRS990/IndependentAuditFinclStmtInd | 0 | false |
| IRS990/IndependentVotingMemberCnt | 0 | 2 |
| IRS990/IndoorTanningServicesInd | 0 | false |
| IRS990/InfoInScheduleOPartIIIInd | 0 | X |
| IRS990/InfoInScheduleOPartIXInd | 0 | X |
| IRS990/InfoInScheduleOPartVIInd | 0 | X |
| IRS990/InformationTechnologyGrp/ProgramServicesAmt | 0 | 1764 |
| IRS990/InformationTechnologyGrp/TotalAmt | 0 | 1764 |
| IRS990/InsuranceGrp/ProgramServicesAmt | 0 | 7117 |
| IRS990/InsuranceGrp/TotalAmt | 0 | 7117 |
| IRS990/InterestGrp/ManagementAndGeneralAmt | 0 | 166 |
| IRS990/InterestGrp/TotalAmt | 0 | 166 |
| IRS990/InvestmentIncomeGrp/ExclusionAmt | 0 | 883 |
| IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt | 0 | 57283 |
| IRS990/InvestmentIncomeGrp/UnrelatedBusinessRevenueAmt | 0 | 56400 |
| IRS990/InvestmentInJointVentureInd | 0 | false |
| IRS990/InvestmentsPubTradedSecGrp/BOYAmt | 0 | 4660 |
| IRS990/InvestmentsPubTradedSecGrp/EOYAmt | 0 | 4660 |
| IRS990/IRPDocumentCnt | 0 | 0 |
| IRS990/IRPDocumentW2GCnt | 0 | 0 |
| IRS990/LandBldgEquipAccumDeprecAmt | 0 | 569413 |
| IRS990/LandBldgEquipBasisNetGrp/BOYAmt | 0 | 2953105 |
| IRS990/LandBldgEquipBasisNetGrp/EOYAmt | 0 | 4678218 |
| IRS990/LandBldgEquipCostOrOtherBssAmt | 0 | 5247631 |
| IRS990/LegalDomicileStateCd | 0 | FL |
| IRS990/LoanOutstandingInd | 0 | true |
| IRS990/LoansFromOfficersDirectorsGrp/BOYAmt | 0 | 251396 |
| IRS990/LoansFromOfficersDirectorsGrp/EOYAmt | 0 | 159953 |
| IRS990/LobbyingActivitiesInd | 0 | false |
| IRS990/LocalChaptersInd | 0 | false |
| IRS990/MaterialDiversionOrMisuseInd | 0 | false |
| IRS990/MembersOrStockholdersInd | 0 | false |
| IRS990/MethodOfAccountingAccrualInd | 0 | X |
| IRS990/MinutesOfCommitteesInd | 0 | true |
| IRS990/MinutesOfGoverningBodyInd | 0 | true |
| IRS990/MissionDesc | 0 | FRONTIERS IN BIOSCIENCE IS AN ORGANIZATION DEDICATED TO FOSTERING SCIENCE, RESEARCH AND TEACHING. FBS HAS BEEN INVOLVED IN THESE ACTIVITIES SINCE JAN 1 1996. FBS HAS PUBLISHED OVER 4000 SCHOLARLY SCIENTIFIC ARTICLES IN MEDICINE AND BIOLOGY FROM WELL KNOWN SCIENTISTS. FBS ALSO CARRIES RESEARCH IN UNDERSTANDING CANCER SINCE 2007 AND HAS BEEN WORKING ON AGING REVERSAL SINCE 2011. OUR RESEARCH ON CANCER IS GEARED TOWARDS UNDERSTANDING THE REASON FOR CANCER GROWTH AND RECURRENCE AS WELL AS UNDERSTANDING THE CAUSE OF DISTURBED METABOLISM (WARBURG'S EFFECT) OF CANCER CELLS. SUCH AN INSIGHT IS SIGNIFICANT SINCE IT PROVIDES US WITH NEW AVENUES FOR TREATMENT OF CANCER OR CANCER CURE. THE TREATMENT OF CANCER BASED, ON OUR HYPOTHESIS, IS FOUNDED ON NEW NON-CHEMOTHERAPEUTIC AND NON-RADIOTHERPAY APPROACHES. WE ALSO EXAMINE THE CAUSE OF SENESCENCE, AS WELL AS APPROACHES FOR REVERSAL OR DECELERATION OF THIS PROCESS. BASED ON SUCH A BACKGROUND, WE WILL EXAMINE WHETHER SENESCENCE CAN BE REVERSED OR DECE |
| IRS990/MoreThan5000KToIndividualsInd | 0 | false |
| IRS990/MoreThan5000KToOrgInd | 0 | false |
| IRS990/NetAssetsOrFundBalancesBOYAmt | 0 | 7101439 |
| IRS990/NetAssetsOrFundBalancesEOYAmt | 0 | 7555290 |
| IRS990/NetUnrelatedBusTxblIncmAmt | 0 | -440 |
| IRS990/NondeductibleContributionsInd | 0 | false |
| IRS990/OccupancyGrp/ProgramServicesAmt | 0 | 13478 |
| IRS990/OccupancyGrp/TotalAmt | 0 | 13478 |
| IRS990/OfficeExpensesGrp/ProgramServicesAmt | 0 | 4765 |
| IRS990/OfficeExpensesGrp/TotalAmt | 0 | 4765 |
| IRS990/OfficerMailingAddressInd | 0 | false |
| IRS990/OperateHospitalInd | 0 | false |
| IRS990/Organization501c3Ind | 0 | X |
| IRS990/OrganizationFollowsSFAS117Ind | 0 | X |
| IRS990/OtherEmployeeBenefitsGrp/FundraisingAmt | 0 | 895 |
| IRS990/OtherEmployeeBenefitsGrp/ManagementAndGeneralAmt | 0 | 895 |
| IRS990/OtherEmployeeBenefitsGrp/ProgramServicesAmt | 0 | 7164 |
| IRS990/OtherEmployeeBenefitsGrp/TotalAmt | 0 | 8954 |
| IRS990/OtherExpensesGrp/Desc | 0 | PROPERTY TAXES |
| IRS990/OtherExpensesGrp/Desc | 1 | LABORATORY SUPPLIES/FEES |
| IRS990/OtherExpensesGrp/Desc | 2 | INVESTMENT HOA DUES |
| IRS990/OtherExpensesGrp/Desc | 3 | INVESTMENT PROPERTY TAXES |
| IRS990/OtherExpensesGrp/ProgramServicesAmt | 0 | 39564 |
| IRS990/OtherExpensesGrp/ProgramServicesAmt | 1 | 31139 |
| IRS990/OtherExpensesGrp/ProgramServicesAmt | 2 | 16432 |
| IRS990/OtherExpensesGrp/ProgramServicesAmt | 3 | 14378 |
| IRS990/OtherExpensesGrp/TotalAmt | 0 | 39564 |
| IRS990/OtherExpensesGrp/TotalAmt | 1 | 31139 |
| IRS990/OtherExpensesGrp/TotalAmt | 2 | 16432 |
| IRS990/OtherExpensesGrp/TotalAmt | 3 | 14378 |
| IRS990/OtherSalariesAndWagesGrp/ProgramServicesAmt | 0 | 160481 |
| IRS990/OtherSalariesAndWagesGrp/TotalAmt | 0 | 160481 |
| IRS990/OthNotesLoansReceivableNetGrp/BOYAmt | 0 | 8179 |
| IRS990/OthNotesLoansReceivableNetGrp/EOYAmt | 0 | 17 |
| IRS990/PartialLiquidationInd | 0 | false |
| IRS990/PayPremiumsPrsnlBnftCntrctInd | 0 | false |
| IRS990/PayrollTaxesGrp/FundraisingAmt | 0 | 2010 |
| IRS990/PayrollTaxesGrp/ManagementAndGeneralAmt | 0 | 2010 |
| IRS990/PayrollTaxesGrp/ProgramServicesAmt | 0 | 16082 |
| IRS990/PayrollTaxesGrp/TotalAmt | 0 | 20102 |
| IRS990/PoliticalCampaignActyInd | 0 | false |
| IRS990/PrincipalOfficerNm | 0 | SIAMAK TABIBZADEH MD |
| IRS990/PriorPeriodAdjustmentsAmt | 0 | 62991 |
| IRS990/ProfessionalFundraisingInd | 0 | false |
| IRS990/ProgramServiceRevenueGrp/RelatedOrExemptFuncIncomeAmt | 0 | 902183 |
| IRS990/ProgramServiceRevenueGrp/TotalRevenueColumnAmt | 0 | 902183 |
| IRS990/ProhibitedTaxShelterTransInd | 0 | false |
| IRS990/PYExcessBenefitTransInd | 0 | false |
| IRS990/PYInvestmentIncomeAmt | 0 | 5914 |
| IRS990/PYOtherExpensesAmt | 0 | 288152 |
| IRS990/PYProgramServiceRevenueAmt | 0 | 923465 |
| IRS990/PYRevenuesLessExpensesAmt | 0 | 346099 |
| IRS990/PYSalariesCompEmpBnftPaidAmt | 0 | 295128 |
| IRS990/PYTotalExpensesAmt | 0 | 583280 |
| IRS990/PYTotalRevenueAmt | 0 | 929379 |
| IRS990/QuidProQuoContributionsInd | 0 | false |
| IRS990/RcvFndsToPayPrsnlBnftCntrctInd | 0 | false |
| IRS990/ReconcilationRevenueExpnssAmt | 0 | 390860 |
| IRS990/RegularMonitoringEnfrcInd | 0 | true |
| IRS990/RelatedEntityInd | 0 | false |
| IRS990/RelatedOrganizationCtrlEntInd | 0 | false |
| IRS990/ReportInvestmentsOtherSecInd | 0 | false |
| IRS990/ReportLandBuildingEquipmentInd | 0 | true |
| IRS990/ReportOtherAssetsInd | 0 | false |
| IRS990/ReportOtherLiabilitiesInd | 0 | false |
| IRS990/ReportProgramRelatedInvstInd | 0 | false |
| IRS990/RevenueAmt | 0 | 902183 |
| IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearAmt | 0 | 883 |
| IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus1YearAmt | 0 | 5914 |
| IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus2YearsAmt | 0 | 7546 |
| IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus3YearsAmt | 0 | 12028 |
| IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus4YearsAmt | 0 | 14686 |
| IRS990ScheduleA/GrossInvestmentIncome509Grp/TotalAmt | 0 | 41057 |
| IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearAmt | 0 | 902183 |
| IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus1YearAmt | 0 | 923465 |
| IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus2YearsAmt | 0 | 1012822 |
| IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus3YearsAmt | 0 | 1060446 |
| IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus4YearsAmt | 0 | 1246544 |
| IRS990ScheduleA/GrossReceiptsAdmissionsGrp/TotalAmt | 0 | 5145460 |
| IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearAmt | 0 | 883 |
| IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus1YearAmt | 0 | 5914 |
| IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus2YearsAmt | 0 | 7546 |
| IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus3YearsAmt | 0 | 12028 |
| IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus4YearsAmt | 0 | 14686 |
| IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/TotalAmt | 0 | 41057 |
| IRS990ScheduleA/InvestmentIncomeCYPct | 0 | 0.01000 |
| IRS990ScheduleA/InvestmentIncomePYPct | 0 | 0.01000 |
| IRS990ScheduleA/PubliclySupportedOrg509a2Ind | 0 | X |
| IRS990ScheduleA/PublicSupportCY509Pct | 0 | 0.99210 |
| IRS990ScheduleA/PublicSupportPY509Pct | 0 | 0.98890 |
| IRS990ScheduleA/PublicSupportTotal509Amt | 0 | 5145460 |
| IRS990ScheduleA/ThirtyThrPctSuprtTestsCY509Ind | 0 | X |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearAmt | 0 | 902183 |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus1YearAmt | 0 | 923465 |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus2YearsAmt | 0 | 1012822 |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus3YearsAmt | 0 | 1060446 |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus4YearsAmt | 0 | 1246544 |
| IRS990ScheduleA/Total509Grp/TotalAmt | 0 | 5145460 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearAmt | 0 | 903066 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus1YearAmt | 0 | 929379 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus2YearsAmt | 0 | 1020368 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus3YearsAmt | 0 | 1072474 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus4YearsAmt | 0 | 1261230 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/TotalAmt | 0 | 5186517 |
| IRS990/ScheduleBRequiredInd | 0 | false |
| IRS990ScheduleD/BuildingsGrp/BookValueAmt | 0 | 1727243 |
| IRS990ScheduleD/BuildingsGrp/DepreciationAmt | 0 | 251702 |
| IRS990ScheduleD/BuildingsGrp/InvestmentCostOrOtherBasisAmt | 0 | 751187 |
| IRS990ScheduleD/BuildingsGrp/OtherCostOrOtherBasisAmt | 0 | 1227758 |
| IRS990ScheduleD/EquipmentGrp/BookValueAmt | 0 | 72799 |
| IRS990ScheduleD/EquipmentGrp/DepreciationAmt | 0 | 271419 |
| IRS990ScheduleD/EquipmentGrp/OtherCostOrOtherBasisAmt | 0 | 344218 |
| IRS990ScheduleD/LandGrp/BookValueAmt | 0 | 2854413 |
| IRS990ScheduleD/LandGrp/InvestmentCostOrOtherBasisAmt | 0 | 1298939 |
| IRS990ScheduleD/LandGrp/OtherCostOrOtherBasisAmt | 0 | 1555474 |
| IRS990ScheduleD/OtherLandBuildingsGrp/BookValueAmt | 0 | 23763 |
| IRS990ScheduleD/OtherLandBuildingsGrp/DepreciationAmt | 0 | 46292 |
| IRS990ScheduleD/OtherLandBuildingsGrp/OtherCostOrOtherBasisAmt | 0 | 70055 |
| IRS990ScheduleD/TotalBookValueLandBuildingsAmt | 0 | 4678218 |
| IRS990/ScheduleJRequiredInd | 0 | false |
| IRS990ScheduleL/BusTrInvolveInterestedPrsnGrp/NameOfInterested/PersonNm | 0 | SIAMAK TABIBZADEH |
| IRS990ScheduleL/BusTrInvolveInterestedPrsnGrp/RelationshipDescriptionTxt | 0 | CEO |
| IRS990ScheduleL/BusTrInvolveInterestedPrsnGrp/SharingOfRevenuesInd | 0 | false |
| IRS990ScheduleL/BusTrInvolveInterestedPrsnGrp/TransactionAmt | 0 | 88000 |
| IRS990ScheduleL/BusTrInvolveInterestedPrsnGrp/TransactionDesc | 0 | LEAD INVESTIGATOR |
| IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/BalanceDueAmt | 0 | 159953 |
| IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/BoardOrCommitteeApprovalInd | 0 | true |
| IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/DefaultInd | 0 | false |
| IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/LoanToOrganizationInd | 0 | X |
| IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/OriginalPrincipalAmt | 0 | 154000 |
| IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/PersonNm | 0 | SIAMAK TABIBZADEH PROMISSORY NOTE |
| IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/RelationshipWithOrgTxt | 0 | CEO |
| IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/WrittenAgreementInd | 0 | true |
| IRS990ScheduleL/SupplementalInformationDetail/ExplanationTxt | 0 | PERSONAL LOAN TO PURCHASE ASSETS DEFERRED SALARIES |
| IRS990ScheduleL/SupplementalInformationDetail/FormAndLineReferenceDesc | 0 | SCHEDULE L, PART V |
| IRS990ScheduleL/TotalBalanceDueAmt | 0 | 159953 |
| IRS990/ScheduleORequiredInd | 0 | true |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 0 | FRONTIERS IN BIOSCIENCE IS AN ORGANIZATION DEDICATED TO FOSTERING SCIENCE, RESEARCH AND TEACHING. FBS HAS BEEN INVOLVED IN THESE ACTIVITIES SINCE JAN 1 1996. FBS HAS PUBLISHED OVER 4000 SCHOLARLY SCIENTIFIC ARTICLES IN MEDICINE AND BIOLOGY FROM WELL KNOWN SCIENTISTS. FBS ALSO CARRIES RESEARCH IN UNDERSTANDING CANCER SINCE 2007 AND HAS BEEN WORKING ON AGING REVERSAL SINCE 2011. OUR RESEARCH ON CANCER IS GEARED TOWARDS UNDERSTANDING THE REASON FOR CANCER GROWTH AND RECURRENCE AS WELL AS UNDERSTANDING THE CAUSE OF DISTURBED METABOLISM (WARBURG'S EFFECT) OF CANCER CELLS. SUCH AN INSIGHT IS SIGNIFICANT SINCE IT PROVIDES US WITH NEW AVENUES FOR TREATMENT OF CANCER OR CANCER CURE. THE TREATMENT OF CANCER BASED, ON OUR HYPOTHESIS, IS FOUNDED ON NEW NON-CHEMOTHERAPEUTIC AND NON-RADIOTHERPAY APPROACHES. WE ALSO EXAMINE THE CAUSE OF SENESCENCE, AS WELL AS APPROACHES FOR REVERSAL OR DECELERATION OF THIS PROCESS. BASED ON SUCH A BACKGROUND, WE WILL EXAMINE WHETHER SENESCENCE CAN BE REVERSED OR DECELARATED IN ANIMAL MODES BEFORE THEY CAN BE ADOPTED IN HUMANS. WE WILL USE STEM CELLS AS WELL SIGNALING MOLECULES TO ACHIEVE SUCH THERAPEUTIC END. WE HOPE THAT OUR FINDINGS WILL HELP HUMANITY IN A GRAND SCALE. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 1 | ALSO EXAMINE THE CAUSE OF SENESCENCE, AS WELL AS APPROACHES FOR REVERSAL OR DECELERATION OF THIS PROCESS. BASED ON SUCH A BACKGROUND, WE WILL EXAMINE WHETHER SENESCENCE CAN BE REVERSED OR DECELARATED IN ANIMAL MODES BEFORE THEY CAN BE ADOPTED IN HUMANS. WE WILL USE STEM CELLS AS WELL SIGNALING MOLECULES TO ACHIEVE SUCH THERAPEUTIC END. WE HOPE THAT OUR FINDINGS WILL HELP HUMANITY IN A GRAND SCALE. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 2 | THE FORM 990 IS REVIEWED WITH THE CPA CONSULTANT AS TO ACCURACY AND COMPLETENESS. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 3 | CONFLICT OF INTEREST POLICY - THE BOARD OF DIRECTORS REVIEWS SELF-DEALING TRANSACTIONS REGULARLY. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 4 | AVAIABLE UPON REQUEST. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 5 | ASSOCIATION DUES 14,126 0 0 MERCHANT SERVICE FEES 13,160 0 0 TRANSPORTATION 12,358 0 0 SOUITH CRESCENT - BUILDING 7,939 0 0 1080 PARK - BUILDING 7,548 0 0 COMMUNICATIONS 6,980 0 0 PACIFIC PROMENADE - BUILDING 5,005 0 0 INVESTMENT MANAGEMENT FEE 4,021 0 0 INVESTMENT OTHER 1,517 0 0 EVENTS 1,399 0 0 BOOKS AND PUBLICATIONS 405 0 0 |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 6 | OFFICER LOAN INTEREST ACCRUED-CURRENT 0 OFFICER LOAN INTEREST ACCRUED-PRIOR 0 OFFICER LOAN INTEREST ACCRUAL 0 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 0 | FORM 990 - ORGANIZATION'S MISSION |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 1 | FORM 990, PAGE 2, PART III, LINE 4A |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 2 | FORM 990, PAGE 6, PART VI, LINE 11B |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 3 | FORM 990, PAGE 6, PART VI, LINE 12C |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 4 | FORM 990, PAGE 6, PART VI, LINE 19 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 5 | FORM 990, PART IX, LINE 24E |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 6 | FORM 990, PART XI, LINE 9 |
| IRS990/SchoolOperatingInd | 0 | false |
| IRS990/SignificantChangeInd | 0 | false |
| IRS990/SignificantNewProgramSrvcInd | 0 | false |
| IRS990/StatesWhereCopyOfReturnIsFldCd | 0 | CA |
| IRS990/SubjectToProxyTaxInd | 0 | false |
| IRS990/TaxablePartyNotificationInd | 0 | false |
| IRS990/TaxExemptBondsInd | 0 | false |
| IRS990/TempOrPermanentEndowmentsInd | 0 | false |
| IRS990/TerminateOperationsInd | 0 | false |
| IRS990/TotalAssetsBOYAmt | 0 | 7380585 |
| IRS990/TotalAssetsEOYAmt | 0 | 7717237 |
| IRS990/TotalAssetsGrp/BOYAmt | 0 | 7380585 |
| IRS990/TotalAssetsGrp/EOYAmt | 0 | 7717237 |
| IRS990/TotalCompGreaterThan150KInd | 0 | false |
| IRS990/TotalEmployeeCnt | 0 | 6 |
| IRS990/TotalFunctionalExpensesGrp/FundraisingAmt | 0 | 11705 |
| IRS990/TotalFunctionalExpensesGrp/ManagementAndGeneralAmt | 0 | 19287 |
| IRS990/TotalFunctionalExpensesGrp/ProgramServicesAmt | 0 | 537614 |
| IRS990/TotalFunctionalExpensesGrp/TotalAmt | 0 | 568606 |
| IRS990/TotalGrossUBIAmt | 0 | 56400 |
| IRS990/TotalLiabilitiesBOYAmt | 0 | 279146 |
| IRS990/TotalLiabilitiesEOYAmt | 0 | 161947 |
| IRS990/TotalLiabilitiesGrp/BOYAmt | 0 | 279146 |
| IRS990/TotalLiabilitiesGrp/EOYAmt | 0 | 161947 |
| IRS990/TotalNetAssetsFundBalanceGrp/BOYAmt | 0 | 7101439 |
| IRS990/TotalNetAssetsFundBalanceGrp/EOYAmt | 0 | 7555290 |
| IRS990/TotalProgramServiceExpensesAmt | 0 | 537614 |
| IRS990/TotalProgramServiceRevenueAmt | 0 | 902183 |
| IRS990/TotalReportableCompFromOrgAmt | 0 | 136502 |
| IRS990/TotalRevenueGrp/ExclusionAmt | 0 | 883 |
| IRS990/TotalRevenueGrp/RelatedOrExemptFuncIncomeAmt | 0 | 902183 |
| IRS990/TotalRevenueGrp/TotalRevenueColumnAmt | 0 | 959466 |
| IRS990/TotalRevenueGrp/UnrelatedBusinessRevenueAmt | 0 | 56400 |
| IRS990/TotLiabNetAssetsFundBalanceGrp/BOYAmt | 0 | 7380585 |
| IRS990/TotLiabNetAssetsFundBalanceGrp/EOYAmt | 0 | 7717237 |
| IRS990/TravelGrp/ProgramServicesAmt | 0 | 3369 |
| IRS990/TravelGrp/TotalAmt | 0 | 3369 |
| IRS990/TrnsfrExmptNonChrtblRltdOrgInd | 0 | false |
| IRS990/TypeOfOrganizationCorpInd | 0 | X |
| IRS990/UnrelatedBusIncmOverLimitInd | 0 | true |
| IRS990/UnrestrictedNetAssetsGrp/BOYAmt | 0 | 7101439 |
| IRS990/UnrestrictedNetAssetsGrp/EOYAmt | 0 | 7555290 |
| IRS990/UponRequestInd | 0 | X |
| IRS990/USAddress/AddressLine1Txt | 0 | 20 SUNSET COVE |
| IRS990/USAddress/CityNm | 0 | NEWPORT COAST |
| IRS990/USAddress/StateAbbreviationCd | 0 | CA |
| IRS990/USAddress/ZIPCd | 0 | 92657 |
| IRS990/VotingMembersGoverningBodyCnt | 0 | 5 |
| IRS990/VotingMembersIndependentCnt | 0 | 2 |
| IRS990/WebsiteAddressTxt | 0 | WWW.BIOSCIENCE.ORG |
| IRS990/WhistleblowerPolicyInd | 0 | true |
| ReturnHeader/BuildTS | 0 | 2017-02-10 21:41:12Z |
| ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd | 0 | true |
| ReturnHeader/BusinessOfficerGrp/PersonNm | 0 | SIAMAK TABIBZADEH MD |
| ReturnHeader/BusinessOfficerGrp/PersonTitleTxt | 0 | PRESIDENT/CEO |
| ReturnHeader/BusinessOfficerGrp/PhoneNum | 0 | 9497158286 |
| ReturnHeader/BusinessOfficerGrp/SignatureDt | 0 | 2016-11-15 |
| ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt | 0 | FRONTIERS IN BIOSCIENCE |
| ReturnHeader/Filer/BusinessNameControlTxt | 0 | FRON |
| ReturnHeader/Filer/EIN | 0 | 593432665 |
| ReturnHeader/Filer/PhoneNum | 0 | 9497158286 |
| ReturnHeader/Filer/USAddress/AddressLine1Txt | 0 | 20 SUNSET COVE |
| ReturnHeader/Filer/USAddress/CityNm | 0 | NEWPORT COAST |
| ReturnHeader/Filer/USAddress/StateAbbreviationCd | 0 | CA |
| ReturnHeader/Filer/USAddress/ZIPCd | 0 | 92657 |
| ReturnHeader/PreparerFirmGrp/PreparerFirmEIN | 0 | 471076451 |
| ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt | 0 | INVISIBLE ACCOUNTING SOLUTIONS AAC |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt | 0 | 23072 LAKE CENTER DRIVE SUITE 210 |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm | 0 | LAKE FOREST |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd | 0 | CA |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd | 0 | 926302899 |
| ReturnHeader/PreparerPersonGrp/PhoneNum | 0 | 9496541400 |
| ReturnHeader/PreparerPersonGrp/PreparationDt | 0 | 2016-11-15 |
| ReturnHeader/PreparerPersonGrp/PreparerPersonNm | 0 | ARDAVAN KEYHAN CPA |
| ReturnHeader/ReturnTs | 0 | 2016-11-15T19:04:08-08:00 |
| ReturnHeader/ReturnTypeCd | 0 | 990 |
| ReturnHeader/TaxPeriodBeginDt | 0 | 2015-01-01 |
| ReturnHeader/TaxPeriodEndDt | 0 | 2015-12-31 |
| ReturnHeader/TaxYr | 0 | 2015 |
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2015 • Form 990Detailed filing. Detailed filing data is available for this year.
Similar nonprofits based on the same Siviq industry and scale cohort. 2015 filings • 501(c)3 • $5M-$10M nonprofits
Mountain Lakes, NJ
View Organization501(c)3
Revenue vs current organization
704% higherAssets vs current organization
96% lowerGlen Allen, VA
View Organization501(c)3
Revenue vs current organization
100% lowerAssets vs current organization
About the sameOmaha, NE
View Organization501(c)3
Revenue vs current organization
84% higherAssets vs current organization
About the sameBrooklyn, NY
View Organization501(c)3
Revenue vs current organization
707% higherAssets vs current organization
46% lower